Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity
Jaeseong Oh, Sojeong Yi, Namyi Gu, Dongseong Shin, Kyung-Sang Yu, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang
Genomics Inform. 2018;16(3):52-58.   Published online 2018 Sep 30     DOI: https://doi.org/10.5808/GI.2018.16.3.52
Citations to this article as recorded by Crossref logo
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects
Inyoung Hwang, Sang Chun Ji, Jaeseong Oh, Hyojin Kim, Hyunju Cha, John Kim, Chang‐Seok Lee, Kyung‐Sang Yu, SeungHwan Lee
Alimentary Pharmacology & Therapeutics.2023; 57(7): 763.     CrossRef
Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
Richard D. Beger, Michael A Schmidt, Rima Kaddurah-Daouk
Metabolites.2020; 10(4): 129.     CrossRef
Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatment
Su Mon Aye, Irene Galani, Mei-Ling Han, Ilias Karaiskos, Darren J Creek, Yan Zhu, Yu-Wei Lin, Tony Velkov, Helen Giamarellou, Jian Li
Journal of Antimicrobial Chemotherapy.2020; 75(10): 2852.     CrossRef